Cytotoxic drugs in combination with the CXCR4 antagonist AMD3100 as a potential treatment option for pediatric rhabdomyosarcoma

Regenbogen, Stephan; Stagno, Matias Julian; Schleicher, Sabine; Schilbach, Karin; Boesmueller, Hans; Fuchs, Joerg; Schmid, Evi; Seitz, Guido

dc.contributor.author	Regenbogen, Stephan
dc.contributor.author	Stagno, Matias Julian
dc.contributor.author	Schilbach, Karin
dc.contributor.author	Schmid, Evi
dc.contributor.author	Seitz, Guido
dc.contributor.author	Schleicher, Sabine Barbara
dc.contributor.author	Bösmüller, Hans
dc.contributor.author	Fuchs, Jörg
dc.date.accessioned	2021-01-26T06:13:44Z
dc.date.available	2021-01-26T06:13:44Z
dc.date.issued	2020
dc.identifier.issn	1791-2423
dc.identifier.uri	http://hdl.handle.net/10900/112008
dc.language.iso	en	de_DE
dc.publisher	Spandidos Publ Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.3892/ijo.2020.5059	de_DE
dc.subject.ddc	610	de_DE
dc.title	Cytotoxic drugs in combination with the CXCR4 antagonist AMD3100 as a potential treatment option for pediatric rhabdomyosarcoma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200929220116_00800
utue.publikation.seiten	289-300	de_DE
utue.personen.roh	Regenbogen, Stephan
utue.personen.roh	Stagno, Matias Julian
utue.personen.roh	Schleicher, Sabine
utue.personen.roh	Schilbach, Karin
utue.personen.roh	Boesmueller, Hans
utue.personen.roh	Fuchs, Joerg
utue.personen.roh	Schmid, Evi
utue.personen.roh	Seitz, Guido
dcterms.isPartOf.ZSTitelID	International Journal of Oncology	de_DE
dcterms.isPartOf.ZS-Issue	1	de_DE
dcterms.isPartOf.ZS-Volume	57	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE